Eltrombopag – a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations
Lucy Cook, Nichola CooperDepartment of Haematology, Imperial Health Care NHS Trust, Hammersmith Hospital, London, UKAbstract: Eltrombopag is one of a number of novel agents recently developed for use in the treatment of patients with immune thrombocytopenia (ITP). Rather than preventing destruction...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/eltrombopag-ndash-a-novel-approach-for-the-treatment-of-chronic-immune-a4711 |